These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 38994113)
1. Xihuang pills targeting the Warburg effect through inhibition of the Wnt/β-catenin pathway in prostate cancer. Lin F; Long Y; Li M; Cai C; Wu Y; You X; Tian X; Zhou Q Heliyon; 2024 Jun; 10(12):e32914. PubMed ID: 38994113 [TBL] [Abstract][Full Text] [Related]
2. Exploring the Pharmacological Mechanisms of Xihuang Pills Against Prostate Cancer Wu Y; You X; Lin Q; Xiong W; Guo Y; Huang Z; Dai X; Chen Z; Mei S; Long Y; Tian X; Zhou Q Front Pharmacol; 2021; 12():791269. PubMed ID: 35342388 [No Abstract] [Full Text] [Related]
3. Systems biology strategy and experimental validation to uncover the pharmacological mechanism of Xihuang Pill in treating non-small cell lung cancer. Zhuang Z; Huang D; Sheng ZR; Ye ZJ; Jiang H; Yuan Y; Qin B; Zhao Y; Pan HF; Tang Y Phytomedicine; 2023 Jan; 108():154491. PubMed ID: 36368285 [TBL] [Abstract][Full Text] [Related]
4. Xihuang pills induce apoptosis in hepatocellular carcinoma by suppressing phosphoinositide 3-kinase/protein kinase-B/mechanistic target of rapamycin pathway. Teng YJ; Deng Z; Ouyang ZG; Zhou Q; Mei S; Fan XX; Wu YR; Long HP; Fang LY; Yin DL; Zhang BY; Guo YM; Zhu WH; Huang Z; Zheng P; Ning DM; Tian XF World J Gastrointest Oncol; 2022 Apr; 14(4):872-886. PubMed ID: 35582102 [TBL] [Abstract][Full Text] [Related]
5. Metabolomics-based discovery of XHP as a CYP3A4 inhibitor against pancreatic cancer. Yang Y; Guo Y; Luo H; Wang M; Chen F; Cui H; Chen P; Yin Z; Li L; Dai Y; Zeng J; Zhao J Front Pharmacol; 2023; 14():1164827. PubMed ID: 37081969 [No Abstract] [Full Text] [Related]
6. Exploring the Regulation Mechanism of Xihuang Pill, Yang K; Zeng L; Ge A; Bao T; Xu T; Xie X; Liu L Front Pharmacol; 2020; 11():825. PubMed ID: 32595497 [TBL] [Abstract][Full Text] [Related]
7. The Key Role of the WNT/β-Catenin Pathway in Metabolic Reprogramming in Cancers under Normoxic Conditions. Vallée A; Lecarpentier Y; Vallée JN Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771718 [TBL] [Abstract][Full Text] [Related]
8. [Xihuang Pills and its main components inhibit PI3K/Akt/mTOR signaling pathways and promote the apoptosis of prostate cancer cells in PC-3 tumor-bearing mice]. Long Y; Wu YR; Guo YM; Luo XJ; Li XF; Huang TT; Huang Z; Liu Z; Chen ZJ; Zhou Q; Tian XF Zhonghua Nan Ke Xue; 2021 Apr; 27(4):340-346. PubMed ID: 34914218 [TBL] [Abstract][Full Text] [Related]
9. Xihuang pill induces pyroptosis and inhibits progression of breast cancer cells via activating the cAMP/PKA signalling pathway. Chen C; Yuan S; Chen X; Xie J; Wei Z Am J Cancer Res; 2023; 13(4):1347-1362. PubMed ID: 37168335 [TBL] [Abstract][Full Text] [Related]
10. Xihuang Pill-destabilized CD133/EGFR/Akt/mTOR cascade reduces stemness enrichment of glioblastoma via the down-regulation of SOX2. Xu L; Duan H; Zou Y; Wang J; Liu H; Wang W; Zhu X; Chen J; Zhu C; Yin Z; Zhao X; Wang Q Phytomedicine; 2023 Jun; 114():154764. PubMed ID: 36963368 [TBL] [Abstract][Full Text] [Related]
11. Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy. Rajan P; Sudbery IM; Villasevil ME; Mui E; Fleming J; Davis M; Ahmad I; Edwards J; Sansom OJ; Sims D; Ponting CP; Heger A; McMenemin RM; Pedley ID; Leung HY Eur Urol; 2014 Jul; 66(1):32-9. PubMed ID: 24054872 [TBL] [Abstract][Full Text] [Related]
12. β-ionone Inhibits Epithelial-Mesenchymal Transition (EMT) in Prostate Cancer Cells by Negatively Regulating the Wnt/β-Catenin Pathway. Fang Q; Que T; Liu B; Dan W; Wei Y; Ren B; Fan Y; Hou T; Zeng J Front Biosci (Landmark Ed); 2022 Dec; 27(12):335. PubMed ID: 36624947 [TBL] [Abstract][Full Text] [Related]
13. Effect and mechanism of miR-217 on drug resistance, invasion and metastasis of ovarian cancer cells through a regulatory axis of CUL4B gene silencing/inhibited Wnt/β-catenin signaling pathway activation. Liu HR; Zhao J Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):94-107. PubMed ID: 33506897 [TBL] [Abstract][Full Text] [Related]
14. Antitumor effects of Xi Huang pills on MDA‑MB‑231 cells in vitro and in vivo. Zheng W; Han S; Jiang S; He X; Li X; Ding H; Cao M; Li P Mol Med Rep; 2018 Aug; 18(2):2068-2078. PubMed ID: 29956784 [TBL] [Abstract][Full Text] [Related]
15. Simvastatin Enhanced Anti-tumor Effects of Bevacizumab against Lung Adenocarcinoma A549 Cells Tu X; Zhang J; Yuan W; Wu X; Xu Z; Qing C Anticancer Agents Med Chem; 2023; 23(19):2083-2094. PubMed ID: 37587804 [TBL] [Abstract][Full Text] [Related]
16. Study of Xuanhuang Pill in protecting against alcohol liver disease using ultra-performance liquid chromatography/time-of-flight mass spectrometry and network pharmacology. Cui X; Du M; Wei K; Dai C; Yang RYH; Zhou B; Luo Z; Yang X; Yu Y; Lin W; Wu Y; Liu Y Front Endocrinol (Lausanne); 2023; 14():1175985. PubMed ID: 37082132 [TBL] [Abstract][Full Text] [Related]
17. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha. Jiang YG; Luo Y; He DL; Li X; Zhang LL; Peng T; Li MC; Lin YH Int J Urol; 2007 Nov; 14(11):1034-9. PubMed ID: 17956532 [TBL] [Abstract][Full Text] [Related]
18. [Effects of Xihuang Pills on proliferation and apoptosis of prostate cancer LNCaP cells based on AR/m TOR signaling pathway]. Dai XJ; Long Y; Zou B; Wu LT; Qiu JF; Wu YR; Deng Z; Wang YL; Zhou Q; Tian XF Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(15):4147-4155. PubMed ID: 37802783 [TBL] [Abstract][Full Text] [Related]
19. PDLIM1 interacts with HK2 to promote gastric cancer progression through enhancing the Warburg effect via Wnt/β-catenin signaling. Lei Y; He L; Li Y; Hou J; Zhang H; Li G Cell Tissue Res; 2024 Jan; 395(1):105-116. PubMed ID: 37930472 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-300 promotes apoptosis and inhibits proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway by targeting CUL4B in pancreatic cancer cells. Zhang JQ; Chen S; Gu JN; Zhu Y; Zhan Q; Cheng DF; Chen H; Deng XX; Shen BY; Peng CH J Cell Biochem; 2018 Jan; 119(1):1027-1040. PubMed ID: 28685847 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]